As in all micro caps,there is always the risk of further capital raisings ,given the high cash outlays initially and the lag in revenue which may be depressing the share price. Hopefully in the next couple of years the company may become profitable and flourish from there.
Ann: Patent granted for cancer vaccine technology, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
